+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mirapex"

CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • March 2024
  • 898 Pages
  • Global
From
From
Disease Analysis: Parkinson's Disease - Product Thumbnail Image

Disease Analysis: Parkinson's Disease

  • Report
  • March 2021
  • 75 Pages
  • Global
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Mirapex (pramipexole dihydrochloride) is a centrally acting dopamine agonist used to treat the symptoms of Parkinson's disease and restless legs syndrome. It is a member of the non-ergoline dopamine agonist class of drugs, which are used to treat Parkinson's disease and other movement disorders. Mirapex works by stimulating dopamine receptors in the brain, which helps to reduce the symptoms of Parkinson's disease and restless legs syndrome. It is available in both immediate-release and extended-release formulations. Mirapex is a popular drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological conditions, including Parkinson's disease, restless legs syndrome, and other movement disorders. It is also used to treat depression and anxiety. Mirapex is generally well-tolerated and has few side effects. Some companies in the Mirapex market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Show Less Read more